Fact CheckerSign in

NCT06685497Recruiting

COLORECTUM+ Digital System for Postoperative Quality Improvement in Colorectal Cancer

Construction and Application of a Digital Postoperative Medical Quality Evaluation and Promotion System for Colorectal Cancer Based on the COLORECTUM+ Model

Source: ClinicalTrials.gov · Last updated 28 Jul 2026

Brief summary (registry, in English)

This is a single-center, prospective, interventional study. A total of 236 colorectal cancer patients who underwent surgery will be enrolled and followed for 52 weeks. The digital healthcare quality management system, based on the COLORECTUM+ model, will be used for post-treatment quality evaluation and continuous improvement. Patients will be managed using an Internet+ post-treatment healthcare management platform. The platform integrates AI technology for real-time symptom analysis and alerts. Patients will report symptoms and health data through the platform, which will generate alerts based on symptom severity to guide appropriate interventions. Follow-up assessments will include patient adherence, satisfaction, quality of life, and healthcare utilization. The study expects to demonstrate that the digital healthcare quality management system improves follow-up rates, enhances patient adherence, reduces unplanned hospital visits, and increases overall patient satisfaction. The findings aim to provide evidence for the implementation of digital management systems in colorectal cancer post-treatment care, potentially leading to improved long-term outcomes for patients.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
236 (estimated)
First submitted
11 Oct 2024
Start date
1 Dec 2024
Primary completion date
1 Sept 2027
Lead sponsor
RenJi Hospital
NCT number
NCT06685497

What you commit to

  • Study type: Interventional
  • Planned participants: 236
  • From 1 Dec 2024 to the primary completion date, 1 Sept 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Uncontrolled psychiatric illness.

Other

  • Unable to access electronic devices that can connect to the internet or mobile communications.
  • The ECOG score is greater than or equal to 3.
  • Deemed unsuitable for participation by the investigator.

Who the study is looking for

  • Over 18 years old.
  • Pathologically confirmed colorectal cancer patients.
  • Underwent surgery at the Colorectal Cancer Diagnosis and Treatment Center, Gastrointestinal Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine.
  • Signed informed consent form.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Shanghai Jiao Tong University School of Medicine, Renji Hospital
Coordinator of this site? Confirm its status
ShanghaiChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.